| 【Company Research】InnoCare Pharma (9969 HK) – Orelabrutinib to initiate trial in multiple sclerosis in US |
| 【Company Research】PA Good Doctor (1833 HK) – Guidelines released for the reimbursement of online medical services |
| 【Company Research】Suntien Green Energy (956 HK) – 3Q20 results miss; weak gas margin dragged earnings |
| 【Company Research】Zoomlion Heavy Industry - H (1157 HK) – Margin risk priced in; Good buying opportunity |
| 【Company Research】Zoomlion Heavy Industry - A (000157 CH) – Margin risk priced in; Good buying opportunity |
| 【Company Research】Tigermed (300347 CH) – Further recovery in 3Q |
| 【Sector Research】China Brokerage Sector – 3Q20 results wrap: growth on robust fee incomes |
| 【Company Research】Weichai Power - A (000338 CH) – 3Q20 profit +37% with improved margin & KION’s operation; Upbeat guidance |
| 【Company Research】Weichai Power - H (2338 HK) – 3Q20 profit +37% with improved margin & KION’s operation; Upbeat guidance |
| 【Company Research】GAC Group (2238 HK) – 3Q20 performance update |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
